CBD is on a Roll, but the FDA is Hitting the Brakes
MJ Business Attorneys
JULY 29, 2019
The letter accused Curaleaf of “illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases.”
Let's personalize your content